Medinet Co., Ltd. (2370) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medinet Co., Ltd. (2370:JPX), powered by AI.

Current Price
¥26
Sector
Healthcare
What is the Medinet Co., Ltd. stock price forecast?

Medinet Co., Ltd. is currently trading at ¥26. View real-time AI analysis on Alpha Lenz.

What is Medinet Co., Ltd. insider trading activity?

View the latest insider trading data for Medinet Co., Ltd. on Alpha Lenz.

What is Medinet Co., Ltd.'s P/E ratio?

View Medinet Co., Ltd.'s valuation metrics on Alpha Lenz.

Medinet Co., Ltd.

JPX · 2370
¥26+1(+4.00%)Market closedJPX regular session 09:00–15:00 JST
Ask about Medinet Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Medinet Co., Ltd.'s ROE is -30.4%. Explore profitability and growth together.

Ask for details

Company Overview

Medinet Co., Ltd. is a biomedical research and development company focused on advancing healthcare solutions through innovative biotechnological approaches. The company's primary purpose is to develop, manufacture, and market a wide array of medical and health-related products with an emphasis on cutting-edge therapies and diagnostic tools. Medinet Co., Ltd. plays a pivotal role in the pharmaceuticals, biotechnology, and therapeutics sectors, primarily targeting regenerative medicine and cell therapy technologies. With a commitment to improving patient outcomes, Medinet collaborates with healthcare professionals and institutes to pioneer novel treatments that address critical unmet medical needs. The company’s comprehensive research and development initiatives are designed to facilitate the development of preclinical programs and clinical trials, underscoring its significance in the life sciences industry. Headquartered in Japan, Medinet Co., Ltd. is strategically positioned in the Asian market yet continually seeks alliances that extend its reach and influence in global markets. The company's contributions to the healthcare industry make it a key player in the ongoing pursuit of medical and health innovation.

SectorHealthcare
IndustryBiotechnology
Employees92

Company Statistics

FY 2025

Profile

N/AMarket Cap
¥810,291,000Revenue
0.00Shares Out
92Employees

Margins

13.54%Gross
-162.45%EBITDA
-178.39%Operating
-167.59%Pre-Tax
-168.10%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

8.54%Rev 3Yr
0.69%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-27.37%ROA
-30.38%ROE
-27.28%ROIC

Financial Health

¥2,170,097,000Cash & Cash Equivalents
¥-1,693,600,000Net Debt
12.61%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Medinet Co., Ltd. (ticker: 2370) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 92 employees.

The current price is 26 with a P/E ratio of -x and P/B of -x.

ROE is -30.38% and operating margin is -178.39%. Annual revenue is $810M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Medinet Co., Ltd. (2370) Stock Forecast 2026 ¥26 — Price, Financials & Analyst Targets | Alpha Lenz